Name: PRME PM647 Catalyst
Start: 2026-06-30

Prime Medicine, Inc.

Catalyst AI-extracted

PM647

Alpha-1 Antitrypsin Deficiency

Resolved

7days ago

Catalyst readout · ~ Jun 30, 2026 estimated

What's at stake A key catalyst for PM647 (Alpha-1 Antitrypsin Deficiency) is expected ~ Jun 30, 2026.

Primary source · SEC 8-K verified 14h ago

“On track to file IND and/or CTA for PM647 in AATD mid-2026”

1 source on file.

Link copied ✓